Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the ...

DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

Set against the backdrop of the NMA conference, Executive Officers from the National Medical Association, Grammy Award Winning Artist and Advocate Raheem DeVaughn, and Gilead Sciences experts, are ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Long Beach’s longtime free mobile testing clinic and many outreach programs will no longer be available to its residents, ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention as a tool ...

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

Chicago, Cook County and Illinois are on the cusp of ending the HIV epidemic in our city, county and state. But that progress ...

A new study shows low rates of pre-exposure prophylaxis (PrEP) prescribing to sexual and gender minority individuals living ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...